Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF and Abraxane in Platinum-Refractory Ovarian Cancer
NCT00466960Phase 2Completed
- Sponsor
- University of Washington
- Start
- May 2006
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of sargramostim in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by University of Washington. Started May 2006; status: completed.
02
Drugs
sargramostim
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00466960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466960.